期刊文献+

T细胞克隆扩增与骨髓增生异常综合征

Clonal Expanded T-Cell Repertoire in MDS——Review
下载PDF
导出
摘要 骨髓增生异常综合征(MDS)是一组异质性的克隆性造血干细胞异常疾病,病人常伴有免疫学异常。T细胞介导的造血前体细胞抑制而导致细胞减少与MDS的发生发展有一定相关性。本文总结了目前基于T细胞受体(TCR)谱系等分析所研究的MDS病人T细胞克隆扩增特点,论述的主要问题包括有:MDS病人自身免疫现象和T细胞介导造血抑制的相关性,MDS病人中T细胞克隆扩增特点,MDS病人T细胞谱系变化,MDS病人胸腺近期输出功能变化,免疫抑制治疗效果与MDS病人T细胞克隆的相关性,以及T细胞克隆分析的临床应用价值等。 The myelodysplastic syndromes (MDS) comprises a heterogeneous group of clonal hematopoietic stem cell disorders, while immunological abnormalities are frequently observed in such patients. T-cell mediated suppression of hematopoietic precursors contributes to the cytopenia and is related to the initiation and development of myelodysplastic syndromes (MDS). In this review, current knowledge concerning the feature of T-cell clonal expansion in MDS based on the analysis of T-cell receptor repertoire is summarized, including following issues: autoimmunity in MDS patients associated with T-cell mediated suppression of hematopoiesis, characteristics of T-ceU clonal expansion in MDS patients, change of T-cell repertoier and recent thymus output function in MDS patients, efficiency of immunosuppressive treatment associated with T- cell clonal expansion in MDS patients and significance of T-cell clonal analysis in clinical application.
作者 李扬秋 杜欣
出处 《中国实验血液学杂志》 CAS CSCD 2010年第3期793-797,共5页 Journal of Experimental Hematology
基金 国家高技术研究发展计划(863计划) 编号2006AA02Z114
关键词 骨髓增生异常综合征 T细胞克隆 T细胞受体 myelodysplastic syndromes T-cell clone T-cell receptor
  • 相关文献

参考文献30

  • 1Maciejewski JP, O'Keefe C, Gondek L, et al. Immune-mediated bone marrow failure syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. Folia Histochem Cytobiol, 2007 ; 45 ( 1 ) :5 - 14.
  • 2Voulgarelis M, Giannouli S, Riffs K, et al. Myelodysplastic- associated autoimmunity: clinical and pathophysiologic concepts. Eur J Clin Invest, 2004; 34 (10) :690- 700.
  • 3Hamblin TJ. Immunological abnormalities in myelodysplastic syndromes. Semin Hematol, 1996 ; 33 (2) : 150 - 162.
  • 4Molldrem JJ, Caples M, Mavroudis D, et al. Antithymocyte globulin for patients with myelodysplasfic syndrome. Br J Haematol, 1997 ; 99 ( 3 ) :699 - 705.
  • 5Molldrem JJ, Jiang YZ, Stetler-Stevenson M, et al. Haematological response of patients with myelodysplastic syndrome to antithymocyte globulin is associated with a loss of lymphocyte- mediated inhibition of CFU-GM and alterations in T-ceU receptor Vβ profiles. Br J Haematol, 1998; 102(5) :1314 - 1322.
  • 6Chamuleau ME, Westers TM, van Dreunen L, et al. Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome. Haematologica, 2009 ; 94(4) :496 -506.
  • 7Kordasti SY, Ingram W, Hayden J, et al. CD4^+ CD25high Foxp3^+ regulatory T cells in myelodysplastic syndrome (MDS). Blood, 2007;110(3) :847 -850.
  • 8Kotsianidis I, Bouchliou I, Nakou E, et al. Kinetics, function and bone marrow trafficking of CD4^+ CD25^+ FOXP3^+ regulatory T cells in myelodysplastic syndromes (MDS). Leukemia, 2009 ; 23 (3) :510 -518.
  • 9Melenhorst JJ, Eniafe R, Follmann D, et al. Molecular and flow cytometric characterization of the CD4 and CD8 T-cell repertoire in patients with myelodysplastic syndrome. Br J Haematol, 2002; 119 ( 1 ) :97 - 105.
  • 10李扬秋.TCR基因结构,重排和多样性.见:李扬秋,林晨,李蒲主编.T细胞受体的研究与应用.北京.人民卫生出版社.2007:53-64.

二级参考文献29

共引文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部